Cargando…

Portuguese version of the CDR plus NACC FTLD: Validation studies

INTRODUCTION: The CDR Dementia Staging Instrument PLUS National Alzheimer’s Coordinating Center (CDR plus NACC FTLD) was developed by adding to the standard CDR two extra domains focused on the main features of frontotemporal lobar degeneration (FTLD): language and behavior/personality. We intended...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Marisa, Tábuas‐Pereira, Miguel, Durães, João, Faustino, Pedro, Simões, Mário R., Kukull, Walter, Knopman, David S., Santana, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710719/
https://www.ncbi.nlm.nih.gov/pubmed/36466956
http://dx.doi.org/10.1002/dad2.12355
_version_ 1784841425648615424
author Lima, Marisa
Tábuas‐Pereira, Miguel
Durães, João
Faustino, Pedro
Simões, Mário R.
Kukull, Walter
Knopman, David S.
Santana, Isabel
author_facet Lima, Marisa
Tábuas‐Pereira, Miguel
Durães, João
Faustino, Pedro
Simões, Mário R.
Kukull, Walter
Knopman, David S.
Santana, Isabel
author_sort Lima, Marisa
collection PubMed
description INTRODUCTION: The CDR Dementia Staging Instrument PLUS National Alzheimer’s Coordinating Center (CDR plus NACC FTLD) was developed by adding to the standard CDR two extra domains focused on the main features of frontotemporal lobar degeneration (FTLD): language and behavior/personality. We intended to perform the validation studies for the European‐Portuguese population. METHODS: A total of 105 participants matched for age, education, and disease staging (35 bvFTD, 35 AD, and 35 controls) were included. A translated‐version of the CDR and the two added domains was administered by a neuropsychologist who was blinded to the diagnosis. RESULTS: The bvFTD group had higher baseline CDR plus NACC FTLD scores compared to the AD and controls. Only the sum‐of‐boxes (SB) score, the behavior/personality, and language domains were able to distinguish between clinical groups. Logistic regression analyses showed that adding the behavior/personality domain with or without language significantly enhanced the discriminating ability. DISCUSSION: Results show that the CDR plus NACC FTLD is a reliable tool in the diagnostic process of bvFTD patients and has an added value in distinguishing them from patients with AD.
format Online
Article
Text
id pubmed-9710719
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97107192022-12-02 Portuguese version of the CDR plus NACC FTLD: Validation studies Lima, Marisa Tábuas‐Pereira, Miguel Durães, João Faustino, Pedro Simões, Mário R. Kukull, Walter Knopman, David S. Santana, Isabel Alzheimers Dement (Amst) Research Articles INTRODUCTION: The CDR Dementia Staging Instrument PLUS National Alzheimer’s Coordinating Center (CDR plus NACC FTLD) was developed by adding to the standard CDR two extra domains focused on the main features of frontotemporal lobar degeneration (FTLD): language and behavior/personality. We intended to perform the validation studies for the European‐Portuguese population. METHODS: A total of 105 participants matched for age, education, and disease staging (35 bvFTD, 35 AD, and 35 controls) were included. A translated‐version of the CDR and the two added domains was administered by a neuropsychologist who was blinded to the diagnosis. RESULTS: The bvFTD group had higher baseline CDR plus NACC FTLD scores compared to the AD and controls. Only the sum‐of‐boxes (SB) score, the behavior/personality, and language domains were able to distinguish between clinical groups. Logistic regression analyses showed that adding the behavior/personality domain with or without language significantly enhanced the discriminating ability. DISCUSSION: Results show that the CDR plus NACC FTLD is a reliable tool in the diagnostic process of bvFTD patients and has an added value in distinguishing them from patients with AD. John Wiley and Sons Inc. 2022-11-30 /pmc/articles/PMC9710719/ /pubmed/36466956 http://dx.doi.org/10.1002/dad2.12355 Text en © 2022 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Lima, Marisa
Tábuas‐Pereira, Miguel
Durães, João
Faustino, Pedro
Simões, Mário R.
Kukull, Walter
Knopman, David S.
Santana, Isabel
Portuguese version of the CDR plus NACC FTLD: Validation studies
title Portuguese version of the CDR plus NACC FTLD: Validation studies
title_full Portuguese version of the CDR plus NACC FTLD: Validation studies
title_fullStr Portuguese version of the CDR plus NACC FTLD: Validation studies
title_full_unstemmed Portuguese version of the CDR plus NACC FTLD: Validation studies
title_short Portuguese version of the CDR plus NACC FTLD: Validation studies
title_sort portuguese version of the cdr plus nacc ftld: validation studies
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710719/
https://www.ncbi.nlm.nih.gov/pubmed/36466956
http://dx.doi.org/10.1002/dad2.12355
work_keys_str_mv AT limamarisa portugueseversionofthecdrplusnaccftldvalidationstudies
AT tabuaspereiramiguel portugueseversionofthecdrplusnaccftldvalidationstudies
AT duraesjoao portugueseversionofthecdrplusnaccftldvalidationstudies
AT faustinopedro portugueseversionofthecdrplusnaccftldvalidationstudies
AT simoesmarior portugueseversionofthecdrplusnaccftldvalidationstudies
AT kukullwalter portugueseversionofthecdrplusnaccftldvalidationstudies
AT knopmandavids portugueseversionofthecdrplusnaccftldvalidationstudies
AT santanaisabel portugueseversionofthecdrplusnaccftldvalidationstudies